[ad_1]

(Reuters) -Well being insurer Cigna Corp (NYSE:) reported a 16.4% fall in second-quarter revenue on Wednesday, harm by larger medical prices, and stated it expects a adverse earnings affect from COVID-19 of about $2.50 per share for 2021.
The corporate, which additionally has a pharmacy advantages administration enterprise, stated its medical prices within the reported quarter grew as demand for non-COVID healthcare companies normalized.
Well being insurers have largely benefited from a decline in affected person use of discretionary healthcare companies as a result of ongoing pandemic, however demand for these companies is recovering as extra People get vaccinated.
Cigna raised the full-year forecast for adverse earnings affect as a result of pandemic from its earlier outlook of about $1.25 per share, however caught to its annual adjusted earnings from operations goal of at the very least $20.20 per share.
The corporate’s medical care ratio, the quantity spent on medical claims versus the earnings from premiums, worsened to 85.4% within the second quarter, from 70.5% a 12 months earlier, in contrast with an estimate of 81.04%, in keeping with 5 analysts polled by Refinitiv.
Cigna stated it now expects its medical care ratio for the total 12 months to be between 83.0% and 84.0%, in contrast with its prior forecast of 81.0% to 82.0%.
Web earnings attributable to shareholders fell to $1.47 billion, or $4.25 per share, within the quarter ended June 30, from $1.75 billion, or $4.73 per share, a 12 months earlier.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury on account of reliance on the data together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding varieties potential.
[ad_2]
Source link